stockrowPerrigo Company plc
PRGO Healthcare Drug Manufacturers Specialty & Generic
Perrigo Company plc’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 2.75% from fiscal 2024.
- Revenue
- −5.24%
- EPS
- −494.6%
- Free cash flow
- +138.5%
- Total debt
- −9.62%
Quarter to September 2026, against a year earlier
Follow PRGO
Alert me
Perrigo Company plc (PRGO) Operating cash flow
Perrigo Company plc's operating cash flow for fiscal 2025 was $238.5M, down 34.3% from $362.9M in fiscal 2024. Over the twelve months to 30 September 2026 it was $240.6M. Over the past ten years it has ranged from $156.3M (fiscal 2021) to $855.2M (fiscal 2015); the current reading is higher than 25% of that period. Perrigo Company plc ranks 16th of 84 Drug Manufacturers Specialty & Generic companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $238.5M | (34.28%) |
| FY2024 | $362.9M | (10.51%) |
| FY2023 | $405.5M | 31.96% |
| FY2022 | $307.3M | 96.61% |
| FY2021 | $156.3M | (75.43%) |
| FY2020 | $636.2M | 64.05% |
| FY2019 | $387.8M | (34.60%) |
| FY2018 | $593.0M | (15.15%) |
| FY2017 | $698.9M | 6.72% |
| FY2016 | $654.9M | 225.98% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $96.2M | 16.46% |
| Jun 2026 | $82.6M | — |
| Mar 2026 | −$113.6M | — |
| Dec 2025 | $175.4M | 239.26% |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| BCRX BioCryst Pharmaceuticals, Inc. compare | $367.5M |
| TRLV Trulieve Cannabis Corp. compare | $242.5M |
| PRGO Perrigo Company plc | $240.6M |
| PBH Prestige Consumer Healthcare Inc. compare | $229.8M |
| ANIP ANI Pharmaceuticals, Inc. compare | $229.2M |
| XERS Xeris Biopharma Holdings, Inc. compare | $73.6M |
| ALVO Alvotech compare | −$11.8M |
| RGC Regencell Bioscience Holdings Limited compare | −$14.7M |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | −$124.8M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on PRGO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement